lycorine has been researched along with Shock, Septic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, X; Diao, Y; Fan, J; Kang, J; Li, G; Luo, L; Wang, Q; Yin, Z; Zhang, Y; Zhao, Z | 1 |
1 other study(ies) available for lycorine and Shock, Septic
Article | Year |
---|---|
Lycorine inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and STATs activation and increases the survival rate of mice after LPS challenge.
Topics: Amaryllidaceae Alkaloids; Animals; Anti-Inflammatory Agents; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Synthase Type II; Phenanthridines; RNA, Messenger; Shock, Septic; STAT1 Transcription Factor; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha; Up-Regulation | 2012 |